Impact of chemotherapy for AIDS-related malignancies in pediatric HIV disease.
Gonzalez
C E
CE
HIV/AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. cgonzalez@cnmc.org
Adde
M
M
Taylor
P
P
Wood
L V
LV
Magrath
I
I
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002648:Child; D015658:HIV Infections / Q000150:complications* / Q000276:immunology; D015497:HIV-1 / Q000187:drug effects / Q000302:isolation & purification / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000209:etiology; D012367:RNA, Viral / Q000097:blood; D014779:Virus Replication / Q000187:drug effects
D012367:RNA, Viral